Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGHS.L Regulatory News (GHS)

  • There is currently no data for GHS

Director/PDMR Shareholding

16 Dec 2021 16:40

RNS Number : 9458V
Gresham House Strategic PLC
16 December 2021
 

Gresham House Strategic plc

 

("Gresham House Strategic" or the "Company")

  

Director/PDMR Shareholdings

 

Gresham House Strategic (AIM: GHS), announces that it received notice on 16 December 2021 that Mr Christopher Mills, via Harwood Capital LLP, Chief Executive of the investment manager, purchased 10,250 ordinary shares in the capital of GHS at a price of 1645.51323 pence per Ordinary Share, on 15 December 2021. 

Following the purchase, Mr Mills' resultant holding in GHS is 96,999 Ordinary Shares, reflecting 2.79% of the Company's issued share capital.

 

For further information, please contact:

Gresham House Strategic plc

Interim Chairman

 

 

Simon Pyper

 

Simon.pyper@me.com

finnCap

Nominated Adviser

Joint Broker

 

 

 

Carl Homes

William Marle

Mark Whitfeld

 

 

020 7220 0500

 

Panmure Gordon (UK) Limited

Joint Broker

 

Tom Scrivens

Michael Bateman

 

020 7886 2500

KL Communications

 

Charles Gorman

Will Sanderson

 

020 3995 6673

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Harwood Capital LLP as investment manager for Harwood HoldCo Limited

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Christopher Mills is Chief Executive of the investment manager, which is also the investment manager for Gresham House Strategic Plc

 

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Gresham House Strategic Plc

b)

 

LEI

 

 

213800K6BRTXR7RNG709

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of £0.50 each

Identification code

GB00BYRH4982

 

b)

 

Nature of the transaction

 

 

Share purchase

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

1645.51323p

10,250

d)

 

Aggregated information

- Aggregated volume

N/A single transaction

- Price

£168,665.11

e)

 

Date of the transaction

 

 

15 December 2021

f)

 

Place of the transaction

 

 

London Stock Exchange

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBLBDDBXBDGBL
Date   Source Headline
23rd Mar 20207:00 amRNSTransaction in Own Shares / Total Voting Rights
16th Mar 20201:42 pmRNSNAV Update
16th Mar 20207:00 amRNSTransaction in Own Shares
9th Mar 20201:00 pmRNSNAV Update
6th Mar 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
2nd Mar 202012:49 pmRNSMonthly NAV Update
28th Feb 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
24th Feb 20202:07 pmRNSNAV Update
21st Feb 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
17th Feb 20202:44 pmRNSNAV Update
14th Feb 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
10th Feb 20202:19 pmRNSNAV Update
3rd Feb 202012:47 pmRNSMonthly NAV Update
31st Jan 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
27th Jan 202012:52 pmRNSNAV Update
24th Jan 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
23rd Jan 20207:00 amRNSQuarterly Factsheet
20th Jan 20202:26 pmRNSNAV Update
17th Jan 20206:26 pmRNSHolding(s) in Company
17th Jan 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
13th Jan 202012:23 pmRNSNAV Update
10th Jan 20206:00 pmRNSTransaction in Own Shares / Total Voting Rights
7th Jan 20203:24 pmRNSDirector/PDMR Shareholding
6th Jan 20201:34 pmRNSNAV Update
3rd Jan 20205:42 pmRNSTransaction in Own Shares / Total Voting Rights
2nd Jan 202012:35 pmRNSMonthly NAV Update
23rd Dec 20194:19 pmRNSHolding(s) in Company
23rd Dec 201911:56 amRNSNAV Update
20th Dec 20195:29 pmRNSTransaction in Own Shares / Total Voting Rights
20th Dec 20197:00 amRNSAppointment of corporate broker
19th Dec 20194:00 pmRNSHolding(s) in Company
19th Dec 20193:55 pmRNSHolding(s) in Company
19th Dec 20193:50 pmRNSHolding(s) in Company
16th Dec 20191:19 pmRNSNAV Update
13th Dec 20196:30 pmRNSTransaction in Own Shares / Total Voting Rights
9th Dec 20191:48 pmRNSNAV Update
2nd Dec 20191:27 pmRNSMonthly NAV Update
29th Nov 20196:15 pmRNSTransaction in Own Shares / Total Voting Rights
26th Nov 20196:30 pmRNSHolding(s) in Company
26th Nov 20197:00 amRNSInterim Results
25th Nov 201912:24 pmRNSNAV Update
22nd Nov 20196:00 pmRNSTransaction in Own Shares / Total Voting Rights
19th Nov 20194:04 pmRNSTransaction in Own Shares & Total Voting Rights
18th Nov 20192:48 pmRNSNAV Update
15th Nov 20195:30 pmRNSTransaction in Own Shares & Total Voting Rights
11th Nov 20191:36 pmRNSNAV Update
8th Nov 20196:00 pmRNSTransaction in Own Shares & Total Voting Rights
4th Nov 20191:55 pmRNSNAV Update
1st Nov 20195:40 pmRNSTransaction in Own Shares & Total Voting Rights
1st Nov 201912:04 pmRNSMonthly NAV Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.